Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy
about
Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy
description
im November 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
Personalized treatment of hepa ...... t resistance-based DAA-therapy
@en
Personalized treatment of hepa ...... t resistance-based DAA-therapy
@nl
type
label
Personalized treatment of hepa ...... t resistance-based DAA-therapy
@en
Personalized treatment of hepa ...... t resistance-based DAA-therapy
@nl
prefLabel
Personalized treatment of hepa ...... t resistance-based DAA-therapy
@en
Personalized treatment of hepa ...... t resistance-based DAA-therapy
@nl
P2093
P1476
Personalized treatment of hepa ...... t resistance-based DAA-therapy
@en
P2093
Anders Lannergård
Ann-Sofi Duberg
Assar Bergfors
Astrid Danielsson
Dario Akaberi
Hege Kileng
Johan Lennerstrand
Lars Wesslén
Magnhild Gangsøy Kristiansen
Midori Kjellin
P304
P356
10.1080/00365521.2018.1511824
P407
P50
P577
2018-10-01T00:00:00Z